KarenLKellyMD

Oncology • Sacramento, CA

Professor of Medicine, UCSD

Join to view full profile

Dr. Kelly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kelly's full profile

Already have an account?

Office
2279 45th St
Sacramento, CA 95817
Phone+1 916-734-5959

Fax+1 916-703-5265

Education & Training

University of ColoradoFellowship, Hematology and Medical Oncology, 1987 - 1990
University of ColoradoResidency, Internal Medicine, 1984 - 1987
University of Kansas School of MedicineClass of 1984

Certifications & Licensure

CA State Medical License 2010 - 2024
CO State Medical License 1986 - 2007
NM State Medical License 1994 - 1997
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Fellow (FASCO) American Society of Clinical Oncologists, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma Start of enrollment: 2010 Mar 15
Active, not recruiting
Phase 1, Phase 2
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 1
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01
Completed
Phase 2
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction Start of enrollment: 2013 Aug 23
Terminated
Phase 1
INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer Start of enrollment: 2013 Aug 27
Completed
Phase 1
Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer Start of enrollment: 2013 Aug 09
Completed
Phase 1
Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction Start of enrollment: 2014 Mar 10
Active, not recruiting
Phase 1
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) Start of enrollment: 2014 Aug 25
Completed
Phase 2
Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer Start of enrollment: 2014 Jul 01
Completed
Phase 1
MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer Start of enrollment: 2015 Dec 03
Terminated
Phase 1
Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer Start of enrollment: 2018 Apr 26
Active, not recruiting
Phase 1
TG4010 and Nivolumab in Patients With Lung Cancer Start of enrollment: 2016 Dec 14
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400).
David Kozono, Xing Hua, Michael C Wu, Khaled A Tolba, Saiama N Waqar
Journal of Thoracic Oncology. 2024-12-01
10 citations
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer.
Jonathan D Spicer, Tina Cascone, Murry W Wynes, Myung-Ju Ahn, Sanja Dacic
Journal of Thoracic Oncology. 2024-10-01
Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study.
Jonathan W Riess, Matthew S Lara, Miguel Lopez de Rodas, Guillaume Luxardi, Samantha Herbert
JTO Clinical and Research Reports. 2024-10-01

Journal Articles

Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint Blockade
R Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase 1b Study
Karen Kelly, Montaser Shaheen, Shadia Jalal, Daruka Mahadevan, Clinical Cancer Research

Lectures

American Society for Radiation Oncology(ASTRO): 20th Chicago Multidisciplinary Symposium inThoracic Oncology
American Society for Radiation Oncology, Chicago, Illinois - 9/6/2012
Great Debates and Updates In Thoracic Malignancies
Imedex, San Francisco, California - 5/5/2012

Press Mentions

BRAF and Lung CancerOctober 1st, 2024
‘Over-Mentored and Under-Sponsored’: Women in Thoracic Oncology Share ChallengesAugust 8th, 2022
Central Coast Hospitals Struggle with Nurse Shortages Amid COVID-19 SurgeSeptember 9th, 2021
Join now to see all